No phaseRecruiting
C2001P-CS3: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
C2001P-CS3 CASCADE: A Feasibility Study of HPV Screening and Management Strategies Utilizing Extended Molecular HPV DNA Genotyping and HPV Viral Load in Women Living With HIV
- Sponsor
- University of California, San Diego (Academic or other)
- Enrollment
- 750 planned
- Conditions
- Human Papillomavirus (HPV); HPV Associated Cancers; Cervical Cancer; Human Immunodeficiency Virus (HIV); Cervical Intraepithelial Neoplasia (CIN)
- Interventions
- HPV DNA Testing (Abbott Alinity m HPV Assay); Visual Inspection with Acetic Acid; Cervical Histology (Biopsy Procedures); Cervical Treatment (Thermal Ablation or LEEP/LLETZ)
- Ages
- adults, older adults
- Registry
- NCT07576842
Full record on ClinicalTrials.gov
From the registry
The overall goal of this study is to inform the design and establish feasibility for a future clinical trial to determine the optimal management of women living with HIV (WLWH) with high-risk human papillomavirus (hrHPV) detected on HPV-based cervical cancer screening. WLWH have a higher diversity of anogenital HPV types causing cervical high-grade squamous intraepithelial lesions (hHSIL) and invasive cancer compared to women without HIV. While there is consensus that women testing positive for HPV 16 and/or 18 should be immediately managed and treated, optimal management strategies for women with other hrHPV types (non-16/18) are not well defined. This prospective cohort study will enroll WLWH undergoing cervical cancer screening using primary HPV testing. Women will self-collect vaginal specimens for hrHPV testing using the Abbott Alinity m HPV assay, which provides extended HPV genotyping and a proxy for HPV viral load based on cycle threshold (CT) values. Women with hrHPV detected will return for further evaluation and treatment as indicated. A subset of women will return at…
Primary outcomes
- Proportion of Potentially Eligible Participants Providing Informed Consent
- Time to Clinic Receipt of HPV Test Results
- Percentage of Participants Receiving HPV Test Results
- Proportion of Participants Returning for Baseline Evaluation
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered